06:06 EST Fortress Biotech (FBIO) files to sell 600,000 shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FBIO:
- Fortress Biotech Amends Credit Agreement with Oaktree
- Optimistic Buy Rating for Fortress Biotech Driven by Promising CUTX-101 Prospects and FDA Engagement
- Fortress Biotech’s CUTX-101 NDA Resubmission Accepted by FDA
- Fortress Biotech, Cyprium announce FDA acceptance of CUTX-101 NDA resubmission
- Fortress Biotech price target raised to $4.50 from $4 at Alliance Global